Matías J Alet: On the Implementation of Tenecteplase for Acute Ischemic Stroke at ESOC 2026
Matías J Alet, Member of Education Committee of World Stroke Organization, shared on LinkedIn:
”I was honored to participate in ESOC 2026 in Maastricht as part of the industry-sponsored satellite symposium ‘Opportunities for improving AIS patient outcomes’.
My talk, ‘Switching to TNK: the real-world experience’, focused on the implementation of tenecteplase for acute ischemic stroke, including international real-world evidence and early lessons from Argentina.
This transition is an opportunity to revisit hyperacute stroke workflows: simplifying administration, reducing treatment delays, improving transfer logistics, and strengthening local quality monitoring.
I am grateful to Boehringer Ingelheim for the invitation.
It was a privilege to share the Argentine perspective in such an important international forum.”
Stay updated with Hemostasis Today.
-
Aug 12, 2026, 10:58Raed Ahmed: New Insights into Severe Vaso-Occlusive Crisis in Pediatric Sickle Cell Disease
-
Aug 12, 2026, 10:27Cliff Oguk: Designing Health AI Around Real-World Clinical Needs
-
Aug 12, 2026, 09:51Orlando Agrippa: Why Promising Sickle Cell Therapies Continue to Fall Short
-
Aug 12, 2026, 09:34Tiffany Hall: Why Hemoglobin Alone Is Not Enough Before Cardiac Surgery
-
Aug 12, 2026, 08:33Craig Clapper: What the Andrea Doria Collision Teaches Us About Safety
-
Aug 12, 2026, 08:16Chengyong Yang: Can Plasma Reveal Cell Specific Signals
-
Aug 12, 2026, 07:49Alan Dursun: Phnom Penh, Cambodia – Part 3 – Turning Partnership into Action
-
Aug 12, 2026, 06:55Alejandro González Veliz: A Good PCI is not Just about Opening the Artery
-
Aug 12, 2026, 06:39Abdulmalik Alnuqydan: Why Do We Transfuse RBCs Less Than 7 Days Old to Newborns?